Consistent with the results of LC-MS/MS proteomics, ROCK1, ROCK2, KPNA2, OGDH, and GLS were significantly downregulated in siEZH2-treated PAH-PASMCs, whereas FAM49B was augmented (Figure 4D). Here, KPNA2 is linked to pulmonary arterial hypertension.